If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
128.00    -2.00 (-1.54%)
Bid:
127.50
Ask:
130.00
Spread: 2.50 (1.961%)
Market Cap: £203.93m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Issue of Options

1 Jul 2019 15:58

RNS Number : 0912E
Redcentric PLC
01 July 2019
 

 

Redcentric plc ("Redcentric" or the "Company")

 

Issue of Options

 

Redcentric plc (AIM: RCN) announces that on 28 June 2019 it granted a total of 1,241,767 options to executive directors and members of the senior management team to acquire new ordinary shares of 0.1 pence each in the Company under the Company's 2017 Long Term Incentive Plan ("LTIP Options"). The LTIP Options are nil-cost options and subject to continued employment and the meeting of certain performance conditions.

 

The following LTIP Options were granted to Directors:

 

Peter Brotherton, Chief Executive Officer: 379,267.

 

As a result, Peter Brotherton holds 1,061,103 share options in the Company. Mr Brotherton also holds 20,000 ordinary shares in the Company.

 

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provides further detail.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Peter Brotherton

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

Legal Entity Identifier

213800FGYMMNE9OKFD14

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options to acquire new ordinary shares of 0.1p each

 

 GB00B7TW1V39

 

b)

Nature of the transaction

Grant of options

c)

Currency

GBP

d)

Price(s) and volume(s)

Price

Volume(s)

Nil cost

379,267

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

N/A - single transaction

 

 

 

f)

Date of the transaction

28 June 2019

g)

Place of the transaction

Outside of a trading venue

 

 

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer +44 (0)845 034 111

Harn Jagpal, Company Secretary +44 (0)845034 111

Tulchan

James Macey White / Matt Low +44 (0)20 7353 4200

Numis Securities Limited - Nomad and Joint Broker +44 (0)20 7260 1000

Simon Willis / Oliver Hardy

finnCap Limited - Joint Broker +44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHRBMITMBAMBAL
Date   Source Headline
22nd Jul 202212:08 pmRNSHolding(s) in Company
21st Jul 20227:01 amRNSAlan Aubrey - AIM Rule 17 Disclosures
21st Jul 20227:00 amRNSPreliminary results announcement FY22
19th Jul 202212:19 pmRNSHolding(s) in Company
12th Jul 20227:00 amRNSAcquisition of Sungard data centres and 4D
7th Jul 20226:25 pmRNSCompletion of Acquisitions
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
9th Jun 20227:00 amRNSDirector/PDMR Shareholding
7th Jun 20228:07 amRNSAcquisition of business and assets of Sungard
12th May 20227:00 amRNSDirectorate Change
28th Apr 20227:00 amRNSTrading Update
27th Apr 20227:00 amRNSNew £100m Bank Facilities
21st Apr 20227:00 amRNSExercise of Options
17th Mar 20227:00 amRNSExercise of Options
15th Mar 20227:00 amRNSAcquisition of 7 Elements Limited
24th Feb 202211:29 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSHolding(s) in Company
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSResponse to outcome of FCA criminal prosecutions
2nd Feb 20221:43 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSTransaction in Own Shares
10th Jan 20227:00 amRNSTransaction in Own Shares
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20227:00 amRNSTransaction in Own Shares
4th Jan 20227:00 amRNSTransaction in Own Shares
31st Dec 202112:27 pmRNSHolding(s) in Company
30th Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSHolding(s) in Company
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20214:48 pmRNSSave As You Earn Option Scheme
17th Dec 20218:22 amRNSNotice of subscription of warrants
24th Nov 20216:20 pmRNSDirector/PDMR Shareholding and Issue of Equity
22nd Nov 20215:30 pmRNSDividend Update
19th Nov 20217:00 amRNSGrant of Options and Director/PDMR Shareholding
18th Nov 20217:01 amRNSHalf Year Results
18th Nov 20217:00 amRNSBoard changes
8th Nov 20212:58 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSTrading Update
20th Oct 20217:00 amRNSIssue of Equity
12th Oct 20217:00 amRNSExercise of Options
5th Oct 20217:00 amRNSIssue of Equity
30th Sep 20217:00 amRNSAcquisition of Piksel Industry Solutions Limited
29th Sep 20217:00 amRNSExercise of Options
9th Sep 20214:11 pmRNSResult of AGM
31st Aug 20217:00 amRNSSave As You Earn Share Option Scheme
9th Aug 20217:00 amRNSPublication of Annual Report and Notice of AGM
26th Jul 20217:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.